The Beauty Health Company
NCM: SKINLive Quote
📈 ZcoreAI Score
Our AI model analyzes The Beauty Health Company's price action across multiple timeframes using regression channels and statistical scoring.
Get SKIN Z-Score →About The Beauty Health Company
Consumer Defensive
Household & Personal Products
The Beauty Health Company, a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.
📊 Fundamental Analysis
The Beauty Health Company demonstrates a profit margin of -3.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported -1.4% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -16.9%, which indicates that capital utilization is currently under pressure.
At a current price of $0.90, SKIN currently trades near the bottom of its 52-week range (7%), indicating potential value or weakness (Range: $0.76 - $2.69).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$114.71M
Trailing P/E
--
Forward P/E
6.91
Beta (5Y)
1.24
52W High
$2.69
52W Low
$0.76
Avg Volume
673K
Day High
Day Low